Taken together, the study’s findings represent a crucial step forward in addressing many unresolved issues regarding Long COVID. The systemic increase in AMPARs provides a direct biological explanation for the cognitive symptoms, highlighting a target for potential treatments. For example, drugs that suppress AMPAR activity could be a viable approach to mitigate brain fog. Interestingly, the team’s analysis also demonstrated that imaging data can be used to distinguish patients from healthy controls with 100% sensitivity and 91% specificity.
It’s unclear if these findings are for Long COVID related brain fog only, or if the other kinds, like the brain fog reported by ME/CFS patients, that fall under this result.
It’s great that strides are made in research for this.
My kid has a lot of similar symptoms to Long COVID (including brain fog) that are attributed to Dysautonomia but all got significantly worse after getting COVID. This has apparently been common for some Dysautonomia patients. I’ll be really curious to see if this leads to improved treatment.
It’s unclear if these findings are for Long COVID related brain fog only, or if the other kinds, like the brain fog reported by ME/CFS patients, that fall under this result.
It’s great that strides are made in research for this.
My kid has a lot of similar symptoms to Long COVID (including brain fog) that are attributed to Dysautonomia but all got significantly worse after getting COVID. This has apparently been common for some Dysautonomia patients. I’ll be really curious to see if this leads to improved treatment.
They’ll probably solve every instance of Long Covid but health insurance will deny trying those findings on ME patients.